|
ADMA | Adma Biologics, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 0.10 |
| Leverage | 24.18% |
| Market Cap | $ 4.3B |
| PE | 20.62 |
| Dividend Yield | 0.00% |
| Profit | $ 208.2m |
| Margin | 42.77% |
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures and markets plasma-derived biological products specialized for the treatment of immunodeficiencies and infectious diseases in the United States. The company is headquartered in Ramsey, New Jersey.